20
nanotimes
Companies Facts
ARWR-Business highlights:
• Began formation of Calando Scientific Advisory Board with the appointment of John J. Rossi, Ph.D. to guide future development of CALAA-01, contribute to partnering activities, initiate new clinical candidates, and expand the RONDEL™ delivery system.
• Increased Arrowhead’s investment in Ablaris Therapeutics to $1.3 million, secured an additional $1.6 million of outside capital, and retained 64% equity in the company.
• Increased investment in Calando Pharmaceuticals via debt conversion and the purchase of preferred stock.
• Completed sale of Unidym to Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based elec- tronics company, for an upfront payment of $5.0 million in Wisepower stock and convertible bonds, retaining upside potential for Unidym stockhol- ders, including Arrowhead, with up to $140m on in earn-out payments and substantially reducing Arrowhead’s burn rate.
http://www.arrowheadresearch.com
ceutical industry over the last 11 years, has been spun out from Avantium Holding BV in a manage- ment buy-out to create Crystallics.
A
Crystallics has developed a number of unique and proprietary technologies both in hardware and software, including High Throughput X-ray Powder Diffraction (HT-XRPD) technology and laboratory informatics, data analysis and predictive models.
http://www.crystallics.com
vantium Pharma BV, a leader in solid state research and pre-formulation for the pharma-
D
avid Edwards is the new Chief Executive Officer of the Singaporean Nanostart (OTCQX: NAS-
RY) holding BioMers Pte Ltd. The top executive will be leveraging his extensive experience in building brands to drive BioMers’ commercial expansion and launch of flagship product, SimpliClear™.
Established in 2005, BioMers is a spin-off company from the National University of Singapore, where the technology was invented. BioMers is a medical device company that has developed novel polymer composite products for numerous biomedical ap- plications. The company’s flagship product is the SimpliClear™ braces system, which is the world’s first and only aesthetic solution for all types of orthodon- tic treatments. This translucent, almost invisible bra- ces system is customized to each patient, providing faster and better results.
http://www.biomersbraces.com
B
iotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announ-
ced the further expansion of its successful family of sample preparation products with the launch of EVOLUTE WAX. The Company is a mixed-mode weak anion exchanger, developed for the extraction of strongly acidic analytes from aqueous samples. The resin-based sorbent is surface modified with well defined hydroxyl-functional oligomers, imparting excellent water wettability. An optimized combina- tion of non-polar (hydrophobic), polar (hydrophilic) and anion exchange interactions allows efficient extraction of strongly acidic analytes of wide ranging polarities.
http://www.biotage.com
11-04 :: April/May 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93